Warby Parker Inc.
Health
Performance
8.3
Risk
Sell
Buy
Curious about the Scores? Learn more.

Warby Parker Inc. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

21.07.2026
Breaking down. The red game over screen is flashing.
21.07.2026
Red alert. Risk levels out of control.
19.07.2026
Losing steam. Not trending your way right now.
20.08.2025
Pulse detected. Still fragile, but stabilizing.
WRBY
Warby Parker Inc.
24.77
+0.73%
8.3
Sell
Buy
Warby Parker Inc.

Warby Parker Inc. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does Warby Parker Inc. do? Business model and key facts

Get the full picture of Warby Parker Inc.: what it builds, where it operates, and how it makes money.

Warby Parker Inc. Profile

Sector: Healthcare

Industry: Medical - Instruments & Supplies

Employees (FY): 2218

Warby Parker Inc. operates as a purveyor of optical products and related services. Their extensive product line includes prescription eyeglasses, sunglasses, and contact lenses, alongside specialized lens options such as light-responsive (photochromic) and blue-light-filtering variants. Customers can also acquire a variety of accessories, including protective cases, lens care kits equipped with anti-fog spray, pouches, and individual anti-fog lens sprays. Beyond product sales, Warby Parker facilitates direct-to-consumer eye examinations and vision assessments. These services are accessible through their physical retail locations, online platform, and dedicated mobile applications. By May 16, 2022, the company had established a network of 160 brick-and-mortar stores across the United States and Canada. Originally incorporated as JAND, Inc. in 2009, the organization officially rebranded to Warby Parker Inc. in June 2021. Its corporate headquarters are situated in New York, New York.

shop
Company facts
Neil Harris Blumenthal
CEO
2218
Employees worldwide
shop
Performance
1.24%
Last 12 months
-54.87%
Last 5 years
shop
Growth
$871.91M
Revenue year
$1.64M
Net income
shop
Valuation
$3.24B
Market Cap
1626.12
Price/Earnings Ratio

Stocks related to Warby Parker Inc.

Selected based on industry alignment and relative market positioning.

HAE
Haemonetics Corporation
78.05
-0.15%
5.8
Sell
Buy
Haemonetics Corporation
ICUI
ICU Medical, Inc.
157.94
+0.38%
4.3
Sell
Buy
ICU Medical, Inc.
MMSI
Merit Medical Systems, Inc.
74.01
-1.54%
4.5
Sell
Buy
Merit Medical Systems, Inc.
XRAY
DENTSPLY SIRONA Inc.
13.62
+1.15%
5.5
Sell
Buy
DENTSPLY SIRONA Inc.
LMAT
LeMaitre Vascular, Inc.
100.99
-0.69%
4.0
Sell
Buy
LeMaitre Vascular, Inc.

Events and news impacting Warby Parker Inc. stock

Earnings, coporate decisions and industry developments that can affect the share price.

Warby Parker Inc. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.